DARIN CHRISTENSEN: Open Payments
NPI 1922093772 · FISHERSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,544 in 121 payments from 15 companies in 2025. Trend: 2023 $1,443 · 2024 $1,985 · 2025 $2,544
Food & beverage: $2,544
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 32 | $508 |
| Neuronetics, Inc. | 7 | $493 |
| ABBVIE INC. | 16 | $234 |
| Vanda Pharmaceuticals Inc. | 11 | $233 |
| Lundbeck LLC | 11 | $220 |
| Janssen Pharmaceuticals, Inc | 6 | $182 |
| Teva Pharmaceuticals USA, Inc. | 8 | $178 |
| Supernus Pharmaceuticals, Inc. | 13 | $149 |
| Otsuka America Pharmaceutical, Inc. | 4 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
Products named: CAPLYTA, NEUROSTAR TMS THERAPY SYSTEM, VRAYLAR, SPRAVATO, UZEDY, FANAPT, ABILIFY MAINTENA, Qelbree.
Industry payments across VA — which companies pay providers there.
